惠理投资盛今：南向资金定价权提升港股中长期配置价值凸显

Core Viewpoint - The Hong Kong stock market is experiencing a significant valuation recovery, driven by a global rebalancing of funds towards non-US markets and asset revaluation led by industry narratives [1][2]. Group 1: Market Trends - The Hang Seng Index has seen a notable decline due to multiple factors, including the strong US dollar impacting emerging market valuations. However, with the weakening dollar and other uncertainties, there is a trend of global funds reallocating towards non-US assets, boosting emerging markets [1]. - As of October 2023, the proportion of overseas active funds allocated to the Chinese market has risen to 7.2%, indicating growing international interest [2]. Group 2: Valuation Insights - The Hang Seng Index's price-to-earnings ratio is projected to be around 10.6 times by the end of 2024, with risk premiums at historical highs, suggesting a high safety margin for investors [2]. - Current valuations of Hong Kong stocks are above historical averages by 1.5 to 1.7 standard deviations, indicating potential short-term pullback pressure, but long-term policy clarity and increased foreign capital inflow are expected to support the market [2]. Group 3: Southbound Capital Influence - Southbound capital's pricing power in the Hong Kong market is strengthening, with daily trading volume from this capital reaching approximately 30% of the main board's total, reflecting its growing influence [3]. - Despite recent volatility in the Hong Kong market, the overall outlook remains optimistic for the medium term [3]. Group 4: Investment Opportunities - Key investment opportunities in the Hong Kong market include: 1. Continued development of the AI industry and improved competition in the internet sector due to "anti-involution" policies, alongside a gradual recovery in certain consumer segments [4]. 2. Strengthening of China's manufacturing advantages and breakthroughs in key technologies, particularly in high-end manufacturing and hard tech sectors [4]. 3. Improved policy environment in the healthcare sector, enhancing competitiveness and growth potential in biopharmaceuticals [4]. 4. Recovery in profit expectations for the chemical and raw materials sectors, making related companies' performance worth monitoring [4]. 5. Potential rotation of capital from high-dividend sectors like telecommunications and utilities towards cyclical and growth assets [4].